Osivax
A clinical stage biotechnology company in France that focuses on developing a pipeline of vaccines and immunotherapies.
5
Funding Rounds
$26.4m
Money raised
Overview
A clinical stage biotechnology company in France that focuses on developing a pipeline of vaccines and immunotherapies.
- Website:
- Business model: B2C
- Headquarters: Lyon
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| Al******* Le**** | - | - | - |
| Fl****** Ni***** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Osivax has raised a total of $26.38m in funding over 5 rounds.
Key Insights:
- Osivax Grant (money), July 2020: $1.34m
- Osivax Grant (money), July 2020: $2.21m
- Osivax Series B round, July 2020: $13.27m
- Osivax Series A round, July 2019: $7.14m
- Osivax Seed round, June 2017: $2.41m
Osivax Grant (money), July 2020
$1.34m
Osivax Grant (money), July 2020
$2.21m
Osivax Series B round, July 2020
$13.27m
Osivax Series A round, July 2019
$7.14m
Osivax Seed round, June 2017
$2.41m
Industries
Osivax is active in the following industries: